(Q39284149)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

review article

2 references

2 October 2020

Recombinant allergy vaccines based on allergen-derived B cell epitopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

2 October 2020

1 reference

2 October 2020

1

Rudolf Valenta

1 reference

PubMed publication ID

10 September 2017

Raffaela Campana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Verena Niederberger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Rudolf Valenta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

1 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 September 2017

1 reference

2 October 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2 October 2020

189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

19-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

19 March 2020

cites work

1 reference

12 December 2020

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

12 December 2020

Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation

1 reference

12 December 2020

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy

1 reference

12 December 2020

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

1 reference

12 December 2020

Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy

1 reference

12 December 2020

The future of antigen-specific immunotherapy of allergy

1 reference

12 December 2020

How IgE upregulates the allergic response

1 reference

12 December 2020

Characteristics and immunobiology of grass pollen allergens.

1 reference

12 December 2020

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

1 reference

12 December 2020

Critical Role of Preconceptional Immunization for Protective and Nonpathological Specific Immunity in Murine Neonates

1 reference

12 December 2020

Vaccination with genetically engineered allergens prevents progression of allergic disease.

1 reference

12 December 2020

Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.

1 reference

12 December 2020

Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

1 reference

12 December 2020

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

12 December 2020

Immunological mechanisms of allergen-specific immunotherapy

1 reference

12 December 2020

Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis

1 reference

12 December 2020

Antigens drive memory IgE responses in human allergy via the nasal mucosa.

1 reference

12 December 2020

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

12 December 2020

Non–IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments

1 reference

12 December 2020

Different allergenic activity of grass pollen allergens revealed by skin testing

1 reference

12 December 2020

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

1 reference

12 December 2020

A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.

1 reference

12 December 2020

From allergen genes to allergy vaccines

1 reference

12 December 2020

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity

1 reference

12 December 2020

Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules

1 reference

12 December 2020

A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.

1 reference

12 December 2020

Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy

1 reference

12 December 2020

Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases

1 reference

12 December 2020

Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives

1 reference

12 December 2020

Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.

1 reference

12 December 2020

Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.

1 reference

12 December 2020

Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts

1 reference

12 December 2020

Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults

1 reference

12 December 2020

Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy.

1 reference

12 December 2020

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype

1 reference

12 December 2020

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

1 reference

12 December 2020

Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.

1 reference

12 December 2020

Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.

1 reference

12 December 2020

Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5.

1 reference

12 December 2020

Microarrayed dog, cat, and horse allergens show weak correlation between allergen-specific IgE and IgG responses

1 reference

12 December 2020

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.

1 reference

12 December 2020

Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.

1 reference

12 December 2020

Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.

1 reference

12 December 2020

Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond

1 reference

12 December 2020

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

1 reference

12 December 2020

Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence

1 reference

12 December 2020

Allergy immunotherapy in reducing healthcare cost

1 reference

12 December 2020

Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children

1 reference

12 December 2020

Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients.

1 reference

12 December 2020

Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.

1 reference

12 December 2020

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future

1 reference

12 December 2020

The role of allergen immunotherapy in the management of allergic rhinitis

1 reference

12 December 2020

Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals.

1 reference

12 December 2020

News in Cellular Allergology: A Review of the Human Mast Cell and Basophil Granulocyte Literature from January 2013 to May 2015.

1 reference

12 December 2020

IgG and IgG4 to 91 allergenic molecules in early childhood by route of exposure and current and future IgE sensitization: Results from the Multicentre Allergy Study birth cohort

1 reference

12 December 2020

EAACI Molecular Allergology User's Guide

1 reference

12 December 2020

Monitoring Allergen Immunotherapy Effects by Microarray

1 reference

12 December 2020

CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.

1 reference

12 December 2020

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.

1 reference

12 December 2020

Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study.

1 reference

12 December 2020

Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine

1 reference

12 December 2020

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

1 reference

12 December 2020

A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.

1 reference

12 December 2020

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

1 reference

12 December 2020

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life

1 reference

12 December 2020

Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

1 reference

12 December 2020

IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future

1 reference

12 December 2020

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.

1 reference

12 December 2020

Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization

1 reference

12 December 2020

Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses

1 reference

12 December 2020

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

1 reference

12 December 2020

IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE

1 reference

12 December 2020

10.1016/J.IMLET.2017.04.015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28472641%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

28472641

1 reference